Medicenna Therapeutics Corp. (MDNA:CA) Discusses New Clinical Data From ABILITY-1 Study Evaluating MDNA11 in Cancer Immunotherapy - Slideshow

SA Transcripts157.29K FollowersFollow5ShareSaveCommentsThe following slide deck was published by Medicenna Therapeutics Corp. in conjunction with this event. This article was written bySA Transcripts157.29K FollowersFollowSeeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts TeamRecommended For You